131 related articles for article (PubMed ID: 37302269)
1. Plasma thiol levels and methylenetetrahydrofolate reductase gene c.665C > T and c.1286A > C variants affect fibrin clot properties in Polish venous thromboembolic patients.
Klajmon A; Głowacki R; Piechocka J; Kopiński P; Ząbczyk M; Natorska J
Mol Genet Metab; 2023 Jul; 139(3):107623. PubMed ID: 37302269
[TBL] [Abstract][Full Text] [Related]
2. SERPINE1 and MTHFR genetic variants in patients with embolic stroke of undetermined source: links with fibrin clot properties.
Klajmon A; Ząbczyk M; Undas A; Natorska J
Neurol Neurochir Pol; 2024 Jun; ():. PubMed ID: 38864767
[TBL] [Abstract][Full Text] [Related]
3. The methylenetetrahydrofolate reductase polymorphism (MTHFR c.677C>T) and elevated plasma homocysteine levels in a U.S. pediatric population with incident thromboembolism.
Joachim E; Goldenberg NA; Bernard TJ; Armstrong-Wells J; Stabler S; Manco-Johnson MJ
Thromb Res; 2013 Aug; 132(2):170-4. PubMed ID: 23866722
[TBL] [Abstract][Full Text] [Related]
4. Methylenetetrahydrofolate reductase (MTHFR) gene c.665C>T and c.1286A>C and SERPINE1 -675 4G/5G polymorphisms in Polish patients with venous thromboembolism and cryptogenic ischemic stroke.
Klajmon A; Cichoń M; Natorska J; Undas A; Wypasek E
Pol Arch Intern Med; 2022 Feb; 132(2):. PubMed ID: 35226442
[No Abstract] [Full Text] [Related]
5. Plasma fibrin clot properties in the G20210A prothrombin mutation carriers following venous thromboembolism: the effect of rivaroxaban.
Janion-Sadowska A; Natorska J; Siudut J; Ząbczyk M; Stanisz A; Undas A
Thromb Haemost; 2017 Aug; 117(9):1739-1749. PubMed ID: 28771277
[TBL] [Abstract][Full Text] [Related]
6. Prothrombotic fibrin clot properties associated with increased endogenous thrombin potential and soluble P-selectin predict occult cancer after unprovoked venous thromboembolism.
Mrozinska S; Cieslik J; Broniatowska E; Malinowski KP; Undas A
J Thromb Haemost; 2019 Nov; 17(11):1912-1922. PubMed ID: 31323706
[TBL] [Abstract][Full Text] [Related]
7. Methylenetetrahydrofolate reductase (MTHFR-677 and MTHFR-1298) genotypes and haplotypes and plasma homocysteine levels in patients with occlusive artery disease and deep venous thrombosis.
Spiroski I; Kedev S; Antov S; Arsov T; Krstevska M; Dzhekova-Stojkova S; Bosilkova G; Kostovska S; Trajkov D; Petlichkovski A; Strezova A; Efinska-Mladenovska O; Spiroski M
Acta Biochim Pol; 2008; 55(3):587-94. PubMed ID: 18800176
[TBL] [Abstract][Full Text] [Related]
8. The role of vitamin B12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene. A case-control study of patients with early-onset thrombotic events.
D'Angelo A; Coppola A; Madonna P; Fermo I; Pagano A; Mazzola G; Galli L; Cerbone AM
Thromb Haemost; 2000 Apr; 83(4):563-70. PubMed ID: 10780318
[TBL] [Abstract][Full Text] [Related]
9. Manifestations of neurological symptoms and thromboembolism in adults with MTHFR-deficiency.
Rommer PS; Zschocke J; Fowler B; Födinger M; Konstantopoulou V; Möslinger D; Stögmann E; Suess E; Baumgartner M; Auff E; Sunder-Plassmann G
J Neurol Sci; 2017 Dec; 383():123-127. PubMed ID: 29246599
[TBL] [Abstract][Full Text] [Related]
10. Molecular and biochemical investigations of patients with intermediate or severe hyperhomocysteinemia.
Sørensen JT; Gaustadnes M; Stabler SP; Allen RH; Mudd SH; Hvas AM
Mol Genet Metab; 2016 Mar; 117(3):344-50. PubMed ID: 26750749
[TBL] [Abstract][Full Text] [Related]
11. High cysteine levels in renal transplant recipients: relationship with hyperhomocysteinemia and 5,10-MTHFR polymorphism.
Marcucci R; Fedi S; Brunelli T; Pepe G; Prisco D; Rosati A; Zanazzi M; Bertoni E; Abbate R; Salvadori M
Transplantation; 2001 Mar; 71(6):746-51. PubMed ID: 11330536
[TBL] [Abstract][Full Text] [Related]
12. Interaction between plasma homocysteine and the MTHFR c.677C > T polymorphism is associated with site-specific changes in DNA methylation in humans.
Nash AJ; Mandaviya PR; Dib MJ; Uitterlinden AG; van Meurs J; Heil SG; Andrew T; Ahmadi KR
FASEB J; 2019 Jan; 33(1):833-843. PubMed ID: 30080444
[TBL] [Abstract][Full Text] [Related]
13. 5,10-Methylenetetrahydrofolate reductase 677C-->T and 1298A-->C mutations are genetic determinants of elevated homocysteine.
Castro R; Rivera I; Ravasco P; Jakobs C; Blom HJ; Camilo ME; de Almeida IT
QJM; 2003 Apr; 96(4):297-303. PubMed ID: 12651974
[TBL] [Abstract][Full Text] [Related]
14. Unfavorably altered plasma clot properties in women with a HERDOO2 score equal to or greater than 2 and prediction of recurrent venous thromboembolism.
Mrozińska S; Cieślik J; Broniatowska E; Undas A
Pol Arch Intern Med; 2018 Oct; 128(10):572-579. PubMed ID: 30113019
[TBL] [Abstract][Full Text] [Related]
15. Mutation (677 C to T) in the methylenetetrahydrofolate reductase gene aggravates hyperhomocysteinemia in hemodialysis patients.
Födinger M; Mannhalter C; Wölfl G; Pabinger I; Müller E; Schmid R; Hörl WH; Sunder-Plassmann G
Kidney Int; 1997 Aug; 52(2):517-23. PubMed ID: 9264011
[TBL] [Abstract][Full Text] [Related]
16. Plasma total homocysteine levels and methylenetetrahydrofolate reductase gene polymorphism in patients with type 2 diabetes mellitus.
Soares AL; Fernandes AP; Cardoso JE; Sousa MO; Lasmar MC; Novelli BA; Lages GF; Dusse LM; Vieira LM; Lwaleed BA; Carvalho MG
Pathophysiol Haemost Thromb; 2008; 36(5):275-81. PubMed ID: 19996639
[TBL] [Abstract][Full Text] [Related]
17. Plasma homocysteine affects fibrin clot permeability and resistance to lysis in human subjects.
Undas A; Brozek J; Jankowski M; Siudak Z; Szczeklik A; Jakubowski H
Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1397-404. PubMed ID: 16574890
[TBL] [Abstract][Full Text] [Related]
18. Associations between folate and choline intake, homocysteine metabolism, and genetic polymorphism of MTHFR, BHMT and PEMT in healthy pregnant Polish women.
Chmurzynska A; Seremak-Mrozikiewicz A; Malinowska AM; Różycka A; Radziejewska A; KurzawiŃska G; Barlik M; Wolski H; Drews K
Nutr Diet; 2020 Jul; 77(3):368-372. PubMed ID: 31044529
[TBL] [Abstract][Full Text] [Related]
19. The C677T MTHFR genotypes influence the efficacy of B9 and B12 vitamins supplementation to lowering plasma total homocysteine in hemodialysis.
Achour O; Elmtaoua S; Zellama D; Omezzine A; Moussa A; Rejeb J; Boumaiza I; Bouacida L; Rejeb NB; Achour A; Bouslama A
J Nephrol; 2016 Oct; 29(5):691-8. PubMed ID: 26559681
[TBL] [Abstract][Full Text] [Related]
20. A cross-sectional study to find out the relationship of methylenetetrahydrofolate reductase (MTHFR) C677T genotype with plasma levels of folate and total homocysteine by daily folate intake in Japanese.
Fukuda N; Hamajima N; Wakai K; Suzuki K
J Nutr Sci Vitaminol (Tokyo); 2014; 60(4):231-8. PubMed ID: 25297611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
